miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer-Reference-Cited by-全球学者库

miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer

Published:2019-06 Issue: Volume:16 Page:471-480
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Lu Zhiyuan,He Qianting,Liang Jianfeng,Li Wuguo,Su Qiao,Chen Zujian,Wan Quan,Zhou Xiaofeng,Cao Laurel,Sun Jingjing,Wu Yu,Liu Lin,Wu Xinming,Hou Jinsong,Lian Keqian,Wang Anxun

Funder

National Program on Key Research Project of China

National Nature Science Foundation of China

Guangzhou Science and Technology Program Project Collaborative Innovation Major Projects

Guangdong Natural Science Foundation

The Science & Technology Planning Project of Guangdong Province

Lilly USA Research Award in Cancer Prevention and Early Detection from Prevent Cancer Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference51 articles.

1. Loss of NDRG2 expression confers oral squamous cell carcinoma with enhanced metastatic potential;Tamura;Cancer Res.,2017

2. Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy;Cabel;Nat. Rev. Clin. Oncol.,2018

3. Development of a standard operating procedure for exosome isolation and analysis using clinical samples: application to cancer biomarker discovery;Setterquist;Proceedings of the 105th Annual Meeting of the American Association for Cancer Research.,2014

4. Epithelial-mesenchymal transition and microRNAs: challenges and future perspectives in oral cancer;Domingues;Head Neck,2018

5. Somatic and germline microRNAs form distinct silencing complexes to regulate their target mRNAs differently;Dallaire;Dev. Cell,2018

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer;Pathology - Research and Practice;2024-01

2. A PRISMA meta-analysis for diagnostic value of microRNA-21 in head and neck squamous cell carcinoma along with bioinformatics research;Oral and Maxillofacial Surgery;2023-12-01

3. Identification of candidate plasma miRNA biomarkers for the diagnosis of head and neck squamous cell carcinoma;Future Science OA;2023-11-22

4. Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident;British Journal of Cancer;2023-10-05

5. Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma;Molecular Biology Reports;2023-09-17